dr. brufsky discusses the tnacity trial
Published 10 years ago • 59 plays • Length 1:41
Download video MP4
Download video MP3
Similar videos
-
1:31
dr. brufsky discusses the tnacity trial
-
1:46
dr. brufsky discusses adjuvant bisphosphonates as a new standard of care
-
1:38
dr. brufsky on the results of a study of trastuzumab and eribulin for her2 mbc
-
1:29
dr. brufsky on the colet trial for triple-negative breast cancer
-
2:47
adam brufsky, md, phd: clinical trial data supporting these choices
-
2:12
dr adam brufsky discusses value coordinates of breast cancer care
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
55:47
5/17/2019 it's a gut feeling: the microbiome in inflammatory disease
-
32:00
dr. vikas dudeja: understanding the gut and tumor connection in pancreatic cancer
-
34:57
the gut-brain connection
-
5:38
case 4: olympiad trial for brca metastatic tnbc
-
1:04
adam brufsky, md, phd: expectations of therapy
-
1:44
adam brufsky, md, phd: choices of therapy in breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
1:07
adam brufsky, md, phd: expectations of therapy in breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
0:49
adam brufsky, md, phd: considerations for different therapies in breast cancer
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
2:39
adam brufsky, md, phd, describes the treatment landscape of her2 metastatic breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:49
cobimetinib plus paclitaxel in tnbc
Clip.africa.com - Privacy-policy